Prospective Observational Study on the Safety and Effectiveness of Imdelltra (tarlatamab) 20230176

04/11/2025
04/11/2025
EU PAS number:
EUPAS1000000778
Study
Planned
Documents
Study protocol
Initial protocol
English (1.14 MB - PDF) View document
Study results
Study report
Other information